FABPulous Overview

  • Founded
  • 2008
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

FABPulous General Information


Developer of an innovative healthcare platform designed to develop and market services for better diagnostics in primary care and emergency medicine. The company's platform develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability, used to conduct rapid tests in the diagnosis of acute myocardial infarction, based on an early biomarker and heart-type fatty acid, enabling physicians to access rapid semi-quantitative diagnostic testing in blood or plasma.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Marconistraat 16
  • 3029 AK Rotterdam
  • Netherlands
+31 043 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FABPulous Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Sep-2018 00.000 Completed Out of Business
5. Later Stage VC 01-Jan-2017 00.000 Completed Generating Revenue
4. Grant 20-Jul-2015 00.000 00.000 Completed Generating Revenue
3. Later Stage VC (Series B) 04-Feb-2015 00.000 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Dec-2009 Completed Startup
1. Early Stage VC Completed Startup
To view FABPulous’s complete valuation and funding history, request access »

FABPulous Executive Team (7)

Name Title Board Seat Contact Info
Hendrik Van den Berg Chief Financial Officer
Jan Glatz Ph.D Founder & Chief Scientific Officer
You’re viewing 2 of 7 executive team members. Get the full list »

FABPulous Board Members (7)

Name Representing Role Since
Duko Driftwood Self Board Member 000 0000
Erik Wolters Self Board Member 000 0000
You’re viewing 2 of 7 board members. Get the full list »